METABICAL Problem Statement Cambridge Sciences Pharmaceuticals (CPS) wishes to determine the best possible target market in order to launch Metabical‚ the new weight-loss prescription drug that’s stipulated to be included in their portfolio. Importance of Positioning Strategies It’s important to note that finding the accurate positioning for any product within the market is crucial‚ given that historically when a product is incorrectly placed it tends to lack
Premium Obesity Health care
What pricing strategy approaches would you suggest PrintUp explore?What are the advantages and disadvantages of each strategy ?What price should you recommend? What pricing strategy approaches would you suggest Printup explore?What are the advantages and disadvantages of each strategy? Comparacion con la competencia: Ventaja: los precios al estar ya fijados sirven como punto de referencia para fijar los precios propios Desventaja: El producto seria similar al de la competencia por parte
Premium Marketing Competition Market
• What is the decision making process for Metabical? ◦ Who is involved? ◦ What role do they play? ◦ What are the stages in the process? In the launch of Metabical for the US market‚ several marketing decisions need to be made to bring a viable product into the market to maximize market penetration and gross margins over the PLC and to best serve the needs of the customers The players are • Health Care Professionals ◦ Will prescribe Metabical to their patients ◦ Can influence Insurance Companies
Premium Marketing
[pic] Business Case Metabical Version 1.0 ● October 21th‚ 2010 [pic] Work Group Metabical – Business Case |VERSION: 1 |REVISION DATE: 10/21/2010 | |Team Members | |Eduardo Lins |[Email] |[Telephone]
Premium Obesity
Case Summary The Cambridge Sciences Pharmaceuticals (“CSP”) is an international healthcare company that had completed successful clinical trials for its newest weight loss prescription drug‚ Metabical. With the final FDA approval expected‚ Metabical’s launch was set for January 2009 and a clear marketing communications strategy needed to be in place before the launch. With 10 years and $400 million spent on research and development‚ it was imperative that CSP positions Metabical correctly in the
Premium Obesity Food and Drug Administration Health care
Case study : Metabical Positining and communication strategy for a new weight-loss drug Question 1 – How should Printup think about the segmentation of potential Metabical consumers? Who is the optimal target consumer? They should target women less than 65 especially (exhibit 2). They seem to be more aware than men to their weight. But most of the population (men and women) are now more conscious that losing weight is important for health. We can talk about normal customers including young
Premium Obesity Weight loss
Metabical Analysis 1) Benefits: * All other Weight-Loss Options in Exhibit 2 are more expensive that the target $30/ month out of pocket cost. * No other weight loss option offers cost containment cards. * No other product combines two mechanisms for weight loss: Metabical combines two pharmacologic mechanisms to produce weight loss: Fat blocker‚ meditonan and appetite suppressant‚ calosera. Due to the dual mechanism‚ the medications can be dosed in lower levels and therefore have
Premium Obesity Prescription drug Pharmacology
Questions for the Harvard case “Metabical: Pricing‚ Packaging‚ and Demand Forecasting for a New Weight-Loss Drug” For March 20‚ write responses to the following questions for the Metabical case. 1) How is Metabical different from the existing weight-loss options? How is it better or worse than the other options? Metabical is the first prescription drug approved specifically for overweight individuals (BMI between 25 and 30)‚ those individuals who have weight-loss goals of approximately
Premium Obesity Weight loss Nutrition
Case Study Metabical Introduction Cambridge Sciences Pharmaceuticals’ (CSP) is international health care company Focus on developing‚ manufacturing and marketing products that treat various deceases Want to enter the market for weight-control products in the US Sucessfully managed to develop Metabical‚ new revolutionary product for weight lost SWOT Analysis Strenghts First prescription drug Has Food and Drug Administration approval Good results in clinical trials and market
Premium
Metabical Case: Pricing‚ Packaging and Demand Forecasting Case Brief Demand Forecasting Packaging and Count Decision Pricing Strategy Introduction of new weight loss drugMetabical What is the expected demand? What are the factors deciding packaging count decisions? How many tablets in a packet of drug? What should be the pricing strategy? ROI Demand Forecastin g Case Brief Packaging and Count Decision Pricing Strategy ROI Demand Forecast: Option One Population Actively Overweight trying
Premium Supply and demand Pricing Household income in the United States